Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-23
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,062320-   
Low Rs768231-   
Sales per share (Unadj.) Rs243.095.1-  
Earnings per share (Unadj.) Rs19.4-24.0-  
Cash flow per share (Unadj.) Rs29.7-19.9-  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs230.374.6-  
Shares outstanding (eoy) m253.70168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.82.9 130.1%   
Avg P/E ratio x47.2-11.5 -410.9%  
P/CF ratio (eoy) x30.8-13.9 -222.3%  
Price / Book Value ratio x4.03.7 107.8%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m232,12046,446 499.8%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m12,8762,915 441.7%   
Avg. sales/employee Rs Th03,739.2-  
Avg. wages/employee Rs Th0679.0-  
Avg. net profit/employee Rs Th0-942.2-  
INCOME DATA
Net Sales Rs m61,64216,052 384.0%  
Other income Rs m1,518112 1,350.1%   
Total revenues Rs m63,16016,165 390.7%   
Gross profit Rs m9,033-2,782 -324.7%  
Depreciation Rs m2,616693 377.5%   
Interest Rs m482435 110.8%   
Profit before tax Rs m7,453-3,797 -196.3%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,534237 1,067.9%   
Profit after tax Rs m4,919-4,045 -121.6%  
Gross profit margin %14.7-17.3 -84.6%  
Effective tax rate %34.0-6.2 -544.0%   
Net profit margin %8.0-25.2 -31.7%  
BALANCE SHEET DATA
Current assets Rs m51,89311,757 441.4%   
Current liabilities Rs m18,0586,615 273.0%   
Net working cap to sales %54.932.0 171.4%  
Current ratio x2.91.8 161.7%  
Inventory Days Days51111 46.2%  
Debtors Days Days6124 4.7%  
Net fixed assets Rs m34,3366,853 501.0%   
Share capital Rs m25475 340.4%   
"Free" reserves Rs m58,1670-   
Net worth Rs m58,42012,599 463.7%   
Long term debt Rs m6,5184,428 147.2%   
Total assets Rs m86,22923,801 362.3%  
Interest coverage x16.5-7.7 -212.9%   
Debt to equity ratio x0.10.4 31.7%  
Sales to assets ratio x0.70.7 106.0%   
Return on assets %6.3-15.2 -41.3%  
Return on equity %8.4-32.1 -26.2%  
Return on capital %12.2-19.8 -61.7%  
Exports to sales %42.90-   
Imports to sales %13.30-   
Net fx Rs m18,2570-   
CASH FLOW
From Operations Rs m8,0581,370 588.1%  
From Investments Rs m-7,250-421 1,723.3%  
From Financial Activity Rs m5,0724,018 126.2%  
Net Cashflow Rs m5,8814,968 118.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.41 Rs / ZAR

Compare IPCA LABS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: WYETH  SMS PHARMA  NATCO PHARMA  TORRENT PHARMA  ANG LIFESCIENCES INDIA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.